01 1Pfizer Ireland Pharmaceuticals
01 1Pfizer Korea
01 1Eletriptan hydrobromide
01 1U.S.A
Registrant Name : Pfizer Korea
Registration Date : 2011-12-09
Registration Number : Su189-14-ND
Manufacturer Name : Pfizer Ireland Pharmaceutica...
Manufacturer Address : Ringaskiddy Active Pharmaceutical Ingredient Plant, PO Box 140, Ringaskiddy, Co. Cork...
95
PharmaCompass offers a list of Eletriptan Hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Eletriptan Hydrobromide manufacturer or Eletriptan Hydrobromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Eletriptan Hydrobromide manufacturer or Eletriptan Hydrobromide supplier.
A Relpax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Relpax, including repackagers and relabelers. The FDA regulates Relpax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Relpax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Relpax manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Relpax supplier is an individual or a company that provides Relpax active pharmaceutical ingredient (API) or Relpax finished formulations upon request. The Relpax suppliers may include Relpax API manufacturers, exporters, distributors and traders.
click here to find a list of Relpax suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Relpax Drug Master File in Korea (Relpax KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Relpax. The MFDS reviews the Relpax KDMF as part of the drug registration process and uses the information provided in the Relpax KDMF to evaluate the safety and efficacy of the drug.
After submitting a Relpax KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Relpax API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Relpax suppliers with KDMF on PharmaCompass.
